The Reply

Affiliations

¹ Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Arizona Health Sciences, Tucson.
² Department of Medicine, University of Arizona Health Sciences, Tucson.
³ Department of Medicine, University of Arizona Health Sciences, Tucson; Sarver Heart Center, University of Arizona Health Sciences, Tucson.

Comment

Bhupinder Natt et al. Am J Med. 2017 Apr.

. 2017 Apr;130(4):e165.

doi: 10.1016/j.amjmed.2016.11.007.

¹ Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Arizona Health Sciences, Tucson.
² Department of Medicine, University of Arizona Health Sciences, Tucson.
³ Department of Medicine, University of Arizona Health Sciences, Tucson; Sarver Heart Center, University of Arizona Health Sciences, Tucson.

No abstract available

Comment on

Pulmonary Embolism with Right Ventricular Dysfunction: Who Should Receive Thrombolytic Agents?
Desai H, Natt B, Bime C, Dill J, Dalen JE, Alpert JS. Desai H, et al. Am J Med. 2017 Jan;130(1):93.e29-93.e32. doi: 10.1016/j.amjmed.2016.07.023. Epub 2016 Aug 24. Am J Med. 2017. PMID: 27566503
Thrombolytic Therapy in Pulmonary Embolism: Treating the Patient, Not Just the Disease.
Biteker M, Özlek E, Özlek B. Biteker M, et al. Am J Med. 2017 Apr;130(4):e163. doi: 10.1016/j.amjmed.2016.10.007. Am J Med. 2017. PMID: 28325232 No abstract available.